Regression analysis describing relationship between TID-adjusted total protein (g) and each TID-adjusted IAA consumption (g). by Bi Xue Patricia Soh (21100364)

Annual territory-wide antigen prevalence for school-based and workplace-based interventions. by Callum Shaw (15628313)

Early CA-DNA accumulation prior to and following ART initiation. by Brandon F. Keele (7450001)

Early CA-RNA accumulation prior to and following ART initiation. by Brandon F. Keele (7450001)

CD8 depletion fails to cause rebound in non-rebounding off-ART RMs. by Brandon F. Keele (7450001)

Consistent barcode distribution across multiple tissues during primary infection. by Brandon F. Keele (7450001)

Total pVL measurements from challenge to treatment interruption. by Brandon F. Keele (7450001)

CA-RNA and CA-DNA viral load measurements from PBMC, peripheral LNMCs, DUO and BM from 3, 70, and 250 dpi. by Brandon F. Keele (7450001)

Early pre- and post-ART plasma viral load dynamics of individual RMs. by Brandon F. Keele (7450001)

Delay in first phase viral decay kinetics when ART is started pre-peak. by Brandon F. Keele (7450001)

Barcode comparisons pre-ART versus post-ART rebound. by Brandon F. Keele (7450001)

Viral measurements do not predict off-ART rebound in d4 and d5 ART RMs. by Brandon F. Keele (7450001)

Intranasal NIC-hLYS is efficacious in vivo against MERS-CoV. by Ashlee D. Brunaugh (4263472)

“…<p>The efficacy of NIC-hLYS particles was assessed in a lethal MERS-CoV infection model (A). Once daily intranasal administration of NIC-hLYS particles suspended in 0.45% sodium chloride resulted in 43% survival in a lethal MERS-CoV infection (B) and produced a statistically significant decrease in lung viral titer at the highest dose tested (C). …”

Intranasal NIC-hLYS is efficacious in vivo against MERS-CoV. by Ashlee D. Brunaugh (4263472)

“…<p>The efficacy of NIC-hLYS particles was assessed in a lethal SARS-CoV-2 infection model (A). Once daily intranasal administration of NIC-hLYS particles suspended in 0.45% sodium chloride resulted in 30% survival in a lethal SARS-CoV-2 infection (B) and produced a statistically significant decrease in lung viral titers after 10 days of dosing (C). …”

Pre-ART plasma barcode proportion during primary infection. by Brandon F. Keele (7450001)

CsrA modulates the expression of a thiamine pyrophosphate (TPP) riboswitch element. by Tobias Sahr (3756775)

“…<b>B</b>) EMSA with 200nM of biotinylated thi-element (TPP) RNA and purified CsrA: Lane 1: no CsrA, lane 2: 1.0 μM CsrA, lane 3: 2.0 μM CsrA, lane 4: 5.0 μM CsrA, lane 5: 5.0 μM CsrA + 2.0 μM unlabeled RsmZ. …”

Histological abnormalities in E18.5 ATF2 mutant cerebellum and brainstem. by Julien Ackermann (223933)

“…Number of hypoglossal motoneurons (h) is bilaterally decreased in <i>Atf2^−/−</i> embryos while number of dorsal vagal motoneurons (v) appears normal. …”

Characteristics of study subjects. by Bi Xue Patricia Soh (21100364)

“…Upon TID adjustment, the percentage of vegans meeting adequacy for protein and IAA decreased and only approximately 50% of the cohort could meet lysine and leucine requirements. …”

Flow chart of study inclusion. by Shayan Shirazian (9922110)

“…The intervention led to modest, but non-significant, increase in KDQOL-physical component summary scores (+3.1±1.2 points) from week 0 to week 16. There were small, non-significant decreases in interdialytic weight gain and pre-dialysis phosphorus levels in the intervention group. …”

Baseline characteristics of the study population. by Shayan Shirazian (9922110)

“…The intervention led to modest, but non-significant, increase in KDQOL-physical component summary scores (+3.1±1.2 points) from week 0 to week 16. There were small, non-significant decreases in interdialytic weight gain and pre-dialysis phosphorus levels in the intervention group. …”